Our findings are supported by a number of studies in other epithelial-derived tumour types, where impaired IL11Rα signalling reduced gastric [18] and prostate cancer growth and metastasis [42], further strengthening the rationale for therapeutically targeting IL11Rα in endometrial cancer. The gene discussed is IL11RA; the disease is prostate cancer.